Effects of Thalidomide and Related Metabolites in a Mouse Corneal Model of Neovascularization
- 30 June 1997
- journal article
- Published by Elsevier in Experimental Eye Research
- Vol. 64 (6), 971-978
- https://doi.org/10.1006/exer.1997.0292
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Definition of Two Angiogenic Pathways by Distinct α v IntegrinsScience, 1995
- Treatment of cutaneous and pulmonary sarcoidosis with thalidomideJournal of the American Academy of Dermatology, 1995
- Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behcet's disease: use of neurophysiological studies to detect thalidomide neuropathy.Annals Of The Rheumatic Diseases, 1994
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- The thalidomide analog, EM 12, enhances 1,2-dimethylhydrazine-induction of rat colon adenocarcinomasCancer Letters, 1991
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- The fate of[14C]thalidomide in the pregnant rabbitBiochemical Journal, 1967
- Toxicity and Teratogenicity of Optical Isomers of ThalidomideNature, 1967
- Effect of Thalidomide on the Graft versus Host ReactionNature, 1966
- Evaluation of the teratogenicity of drugsClinical Pharmacology & Therapeutics, 1964